Here's a summary of the attached investor presentation: **1. Financial Highlights:** FY25 revenue ₹660.73 Cr, net profit ₹41.00 Cr.

Q1FY26 revenue rose 2.05% YoY to ₹140.29 Cr.

EBITDA dipped 13.96% to ₹13.07 Cr (9.31% margin), net profit fell 14.17% to ₹7.43 Cr due to global headwinds & plant maintenance.

Strong FY25 cash (₹41.72 Cr), debt reduced. **2. Strategic Initiatives & Growth Drivers:** R&D drove 43 new products, including battery/hydrogen import substitutes.

A 2.6 MW captive solar provides 100% green energy, boosting efficiency.

Facilities offer expansion headroom. **3. Business Developments:** APL pioneered MDEA in India, now a global leader in MEDA-based solvents/NMMO.

Global MNC collaborations advance custom product development, building a robust new molecule pipeline. **4. Market Position & Competitive Advantage:** APL commands 75-80% domestic ethanolamines market share and is a top global NMMO producer.

High entry barriers (complex chemistries, strict compliance) and diversified global clientele fortify its model. **5. Investor Implications:** Despite Q1FY26 profit dip from maintenance/exports, APL's domestic resilience, active R&D pipeline, and green energy focus indicate positive long-term potential.

Watch new product execution & export recovery.